首页> 外国专利> Treatment or prevention of surgically induced cachexia and / or expression of bone marrow-derived suppressor cells and inflammatory cytokines

Treatment or prevention of surgically induced cachexia and / or expression of bone marrow-derived suppressor cells and inflammatory cytokines

机译:治疗或预防手术诱发的恶病质和/或骨髓源性抑制细胞和炎性细胞因子的表达

摘要

Special immunonutrient supplements can be administered to surgical patients to reduce post-operative complications by inhibiting the growth of bone marrow-derived suppressor cells. The supplement comprises one or more of L-arginine, omega-3 fatty acids, vitamin A, and dietary nucleotides, preferably all four of these compounds. The supplement is administered to the patient at least once per day for a period from one day before surgery, which is 3-7 days before the patient's bladder surgery, to one day after surgery, which is 3-7 days after the bladder surgery. The Administering supplements to treat or prevent postoperative paralytic ileus in patients with bladder cancer; treat or prevent cachexia induced by surgery, inflammation induced or cancer induced Reducing the incidence of chronic infection due to proliferation of bone marrow-derived suppressor cells in the patient; and / or reducing mRNA expression of inflammatory cytokines in the patient. [Selection figure] None
机译:特殊的免疫营养补充剂可用于外科手术患者,以通过抑制骨髓来源的抑制细胞的生长来减少术后并发症。该补充剂包含L-精氨酸,ω-3脂肪酸,维生素A和饮食核苷酸中的一种或多种,​​优选所有这些化合物中的全部四种。从手术前的一天,即患者的膀胱手术之前的3-7天,到手术后的一天,即膀胱手术之后的3-7天,每天至少一次向患者施用补充剂。用于治疗或预防膀胱癌患者术后麻痹性肠梗阻的补充剂;治疗或预防由手术,炎症或癌症引起的恶病质。减少由于患者体内骨髓源性抑制细胞的增殖而引起的慢性感染的发生率;和/或降低患者中炎性细胞因子的mRNA表达。 [选择图]无

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号